Latest research report on “Generic Injectable Drugs Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5614531
Generic injectable drugs refer to sterile solutions (including emulsions and suspensions) made of drugs for injection into the body, and sterile powders or concentrated solutions that are prepared into solutions or suspensions before use.
The injection is fast and reliable, not affected by pH, enzymes, food, etc., has no first-pass effect, and can play a systemic or local positioning effect. It is suitable for patients who are not suitable for oral medicine and patients who cannot be taken orally. However, the development and production process of injections is complicated and safe. The body has poor adaptability and high cost.
This report contains market size and forecasts of Generic Injectable Drugs in Global, including the following market information:
Global Generic Injectable Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Generic Injectable Drugs market was valued at 31500 million in 2021 and is projected to reach US$ 39670 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Small Molecule Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Generic Injectable Drugs include Hospira (Pfizer Inc.), Fresenius Kabi, Sandoz (Novartis), Hikma Pharmaceuticals PLC, Dr. Reddys Laboratories Ltd, Grifols, Nichi-Iko Group (Sagent), Teva Pharmaceutical and Auromedics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Generic Injectable Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Generic Injectable Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Generic Injectable Drugs Market Segment Percentages, by Type, 2021 (%)
– Small Molecule
– Large Molecule
Global Generic Injectable Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Generic Injectable Drugs Market Segment Percentages, by Application, 2021 (%)
– Parenteral Nutrition
– Cardiovascular Diseases
Global Generic Injectable Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Generic Injectable Drugs Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Generic Injectable Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Generic Injectable Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– Hospira (Pfizer Inc.)
– Fresenius Kabi
– Sandoz (Novartis)
– Hikma Pharmaceuticals PLC
– Dr. Reddys Laboratories Ltd
– Nichi-Iko Group (Sagent)
– Teva Pharmaceutical
– Gland Pharma
– Endo International PLC
More information about Discount offers (20% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5614531
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441